| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | protein localization to cell cortex | 4.32e-06 | 12 | 57 | 3 | GO:0072697 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SART3 LUC7L CWF19L2 PUS3 SNW1 SMG7 TCERG1 PNN PRPF3 ROCK1 SCAF11 | 3.57e-05 | 917 | 57 | 11 | GO:0016071 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 5.61e-05 | 358 | 57 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.61e-05 | 358 | 57 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 6.02e-05 | 362 | 57 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA splicing | 6.75e-05 | 502 | 57 | 8 | GO:0008380 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell cortex | 1.12e-04 | 6 | 57 | 2 | GO:1904778 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.29e-04 | 551 | 57 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 2.61e-04 | 45 | 57 | 3 | GO:0030866 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell cortex | 2.67e-04 | 9 | 57 | 2 | GO:1904776 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 LUC7L CWF19L2 MIS18BP1 SNW1 NUP155 SMG7 PNN PRPF3 MCM3 RPA1 EPB41L2 PHF21A | 5.45e-05 | 1377 | 56 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear replication fork | 1.94e-04 | 42 | 56 | 3 | GO:0043596 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.74e-04 | 215 | 56 | 5 | GO:0005681 | |
| Domain | Ez/rad/moesin-like | 1.92e-03 | 21 | 58 | 2 | IPR000798 | |
| Domain | FERM_CS | 2.50e-03 | 24 | 58 | 2 | IPR019747 | |
| Domain | FERM_C | 2.94e-03 | 26 | 58 | 2 | PF09380 | |
| Domain | FERM_C | 3.16e-03 | 27 | 58 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 3.16e-03 | 27 | 58 | 2 | IPR018980 | |
| Domain | FERM_N | 4.70e-03 | 33 | 58 | 2 | PF09379 | |
| Domain | FERM_N | 4.70e-03 | 33 | 58 | 2 | IPR018979 | |
| Domain | TPR-like_helical_dom | 5.91e-03 | 233 | 58 | 4 | IPR011990 | |
| Domain | FERM_M | 8.99e-03 | 46 | 58 | 2 | PF00373 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.88e-05 | 283 | 45 | 7 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.38e-05 | 212 | 45 | 6 | M14033 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 9.90e-05 | 5 | 45 | 2 | M49031 | |
| Pathway | REACTOME_FANCONI_ANEMIA_PATHWAY | 2.56e-04 | 39 | 45 | 3 | MM15318 | |
| Pathway | REACTOME_FANCONI_ANEMIA_PATHWAY | 2.56e-04 | 39 | 45 | 3 | M14990 | |
| Pathway | PID_RHOA_PATHWAY | 3.93e-04 | 45 | 45 | 3 | M12 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.96e-04 | 724 | 45 | 9 | M16843 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 CWF19L2 MIS18BP1 SMG7 TCERG1 CENPE UBR5 CCDC174 ITSN1 MCM3 ROCK1 CEP131 | 2.14e-10 | 588 | 58 | 12 | 38580884 |
| Pubmed | 4.10e-10 | 169 | 58 | 8 | 31462741 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 CWF19L2 SNW1 MAP7D3 TCERG1 PNN PRPF3 CCDC174 NOP53 NUMA1 MCM3 SCAF11 MPHOSPH8 MEF2D | 4.11e-10 | 954 | 58 | 14 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 LUC7L EME1 SNW1 MAP7D3 TCERG1 PNN PRPF3 C16orf87 NUMA1 SCAF11 MPHOSPH8 RPA1 PHF21A TFE3 | 2.21e-09 | 1294 | 58 | 15 | 30804502 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 EZR CWF19L2 SNW1 TCERG1 PRPF3 RPA1 MEF2D EPB41L2 PHF21A | 3.14e-09 | 444 | 58 | 10 | 34795231 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SNW1 NUP155 MAP7D3 TCERG1 PNN CENPE PRPF3 NOP53 NUMA1 SCAF11 NKAP EXOC7 | 3.81e-09 | 759 | 58 | 12 | 35915203 |
| Pubmed | EZR SESTD1 SNW1 CENPE UBR5 ITSN1 NUMA1 MCM3 ROCK1 CEP131 RPA1 CCDC177 EPB41L2 | 5.17e-09 | 963 | 58 | 13 | 28671696 | |
| Pubmed | SNW1 SMG7 TCERG1 PNN CCDC174 NOP53 NUMA1 SCAF11 CEP131 RHOT2 HNF4A RPA1 MEF2D PHF21A TFE3 | 8.41e-09 | 1429 | 58 | 15 | 35140242 | |
| Pubmed | SART3 CASP8AP2 MIS18BP1 SNW1 NUP155 TCERG1 PNN UBR5 PRPF3 NUMA1 MCM3 MPHOSPH8 RPA1 | 9.54e-09 | 1014 | 58 | 13 | 32416067 | |
| Pubmed | 1.33e-08 | 263 | 58 | 8 | 34702444 | ||
| Pubmed | 1.68e-08 | 390 | 58 | 9 | 17643375 | ||
| Pubmed | 2.04e-08 | 399 | 58 | 9 | 37536630 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.48e-08 | 184 | 58 | 7 | 32908313 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 SNW1 FAM193A SMG7 MAP7D3 TCERG1 PNN PRPF3 NUMA1 RPA1 EPB41L2 PHF21A | 3.76e-08 | 934 | 58 | 12 | 33916271 |
| Pubmed | 9.41e-08 | 339 | 58 | 8 | 30415952 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EZR LUC7L SNW1 NUP155 PNN UBR5 PRPF3 NUMA1 MCM3 CEP131 RPA1 EPB41L2 | 1.02e-07 | 1024 | 58 | 12 | 24711643 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 EZR SNW1 NUP155 MAP7D3 TCERG1 PNN PRPF3 NOP53 NUMA1 MCM3 SCAF11 EPB41L2 | 1.17e-07 | 1257 | 58 | 13 | 36526897 |
| Pubmed | 1.30e-07 | 660 | 58 | 10 | 32780723 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 MIS18BP1 SNW1 NUP155 TCERG1 PNN UBR5 PRPF3 NUMA1 MCM3 RHOT2 RPA1 EPB41L2 | 2.72e-07 | 1353 | 58 | 13 | 29467282 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.95e-07 | 394 | 58 | 8 | 27248496 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EZR LUC7L NUP155 MAP7D3 TCERG1 PNN PRPF3 NOP53 NUMA1 MCM3 RPA1 | 4.16e-07 | 949 | 58 | 11 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 EZR LUC7L SNW1 NUP155 TCERG1 PNN UBR5 PRPF3 NUMA1 MCM3 SCAF11 EPB41L2 | 4.53e-07 | 1415 | 58 | 13 | 28515276 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.63e-07 | 283 | 58 | 7 | 30585729 | |
| Pubmed | 1.29e-06 | 653 | 58 | 9 | 22586326 | ||
| Pubmed | 1.41e-06 | 210 | 58 | 6 | 16565220 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 EZR SESTD1 MAP7D3 PRPF3 MCM3 CEP131 NKAP KLC4 EXOC7 RPA1 PHF21A | 1.52e-06 | 1321 | 58 | 12 | 27173435 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.84e-06 | 220 | 58 | 6 | 35785414 | |
| Pubmed | 1.84e-06 | 503 | 58 | 8 | 16964243 | ||
| Pubmed | 2.49e-06 | 708 | 58 | 9 | 39231216 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 26848864 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15314151 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 EZR SNW1 NUP155 CENPE UBR5 PRPF3 P3H1 NUMA1 CEP131 NKAP | 2.81e-06 | 1155 | 58 | 11 | 20360068 |
| Pubmed | EZR NUP155 MAP7D3 PNN CENPE UBR5 P3H1 MCM3 RHOT2 ITGA1 EXOC7 | 3.13e-06 | 1168 | 58 | 11 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 EZR SNW1 NUP155 TCERG1 PNN NOP53 NUMA1 MCM3 MPHOSPH8 RPA1 EPB41L2 | 3.32e-06 | 1425 | 58 | 12 | 30948266 |
| Pubmed | 3.51e-06 | 549 | 58 | 8 | 38280479 | ||
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 3.59e-06 | 247 | 58 | 6 | 32989298 | |
| Pubmed | SART3 LUC7L NUP155 PNN UBR5 PRPF3 NOP53 NUMA1 MCM3 RHOT2 EXOC7 RPA1 | 3.69e-06 | 1440 | 58 | 12 | 30833792 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.14e-06 | 774 | 58 | 9 | 15302935 | |
| Pubmed | 5.30e-06 | 777 | 58 | 9 | 35844135 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 5.76e-06 | 1005 | 58 | 10 | 19615732 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 6.10e-06 | 271 | 58 | 6 | 32433965 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.18e-06 | 807 | 58 | 9 | 22681889 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 7.69e-06 | 1284 | 58 | 11 | 17353931 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20551903 | ||
| Pubmed | Activated ezrin controls MISP levels to ensure correct NuMA polarization and spindle orientation. | 8.19e-06 | 3 | 58 | 2 | 29669740 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 11387207 | ||
| Pubmed | NuMA interacts with phosphoinositides and links the mitotic spindle with the plasma membrane. | 8.19e-06 | 3 | 58 | 2 | 24996901 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12239178 | ||
| Pubmed | Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. | 8.19e-06 | 3 | 58 | 2 | 10970850 | |
| Pubmed | 8.37e-06 | 1049 | 58 | 10 | 27880917 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.12e-05 | 853 | 58 | 9 | 28718761 | |
| Pubmed | 1.24e-05 | 653 | 58 | 8 | 33742100 | ||
| Pubmed | 1.62e-05 | 486 | 58 | 7 | 20936779 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18941185 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12374753 | ||
| Pubmed | Detection of snRNP assembly intermediates in Cajal bodies by fluorescence resonance energy transfer. | 1.64e-05 | 4 | 58 | 2 | 15452143 | |
| Pubmed | SLFN11 Blocks Stressed Replication Forks Independently of ATR. | 1.64e-05 | 4 | 58 | 2 | 29395061 | |
| Pubmed | 1.73e-05 | 491 | 58 | 7 | 36273042 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.93e-05 | 332 | 58 | 6 | 32786267 | |
| Pubmed | 1.98e-05 | 95 | 58 | 4 | 29490077 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 18794151 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 18395097 | ||
| Pubmed | No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk. | 2.72e-05 | 5 | 58 | 2 | 25192705 | |
| Pubmed | 2.84e-05 | 733 | 58 | 8 | 34672954 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.90e-05 | 357 | 58 | 6 | 37059091 | |
| Pubmed | 3.02e-05 | 215 | 58 | 5 | 35973513 | ||
| Pubmed | 3.52e-05 | 222 | 58 | 5 | 37071664 | ||
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 3.56e-05 | 38 | 58 | 3 | 36674791 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 3.58e-05 | 989 | 58 | 9 | 36424410 | |
| Pubmed | SUMOylated NKAP is essential for chromosome alignment by anchoring CENP-E to kinetochores. | 4.08e-05 | 6 | 58 | 2 | 27694884 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.09e-05 | 582 | 58 | 7 | 20467437 | |
| Pubmed | 5.15e-05 | 396 | 58 | 6 | 26687479 | ||
| Pubmed | 5.37e-05 | 399 | 58 | 6 | 35987950 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 12082081 | ||
| Pubmed | Cortical dynein and asymmetric membrane elongation coordinately position the spindle in anaphase. | 5.71e-05 | 7 | 58 | 2 | 23870127 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 21639856 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 34099675 | ||
| Pubmed | A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. | 5.71e-05 | 7 | 58 | 2 | 18082604 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 5.96e-05 | 248 | 58 | 5 | 27926873 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 6.24e-05 | 410 | 58 | 6 | 26949251 | |
| Pubmed | 6.31e-05 | 251 | 58 | 5 | 31076518 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 6.49e-05 | 605 | 58 | 7 | 28977666 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 6.76e-05 | 130 | 58 | 4 | 35545047 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 7.15e-05 | 1082 | 58 | 9 | 38697112 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 7983158 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 20595234 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 7.61e-05 | 134 | 58 | 4 | 25452129 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 7.82e-05 | 847 | 58 | 8 | 35235311 | |
| Pubmed | 7.82e-05 | 847 | 58 | 8 | 35850772 | ||
| Pubmed | SART3 LUC7L SNW1 TCERG1 NUMA1 SCAF11 CEP131 NKAP RPA1 EPB41L2 | 8.15e-05 | 1371 | 58 | 10 | 36244648 | |
| Pubmed | 8.28e-05 | 1103 | 58 | 9 | 34189442 | ||
| Pubmed | 8.59e-05 | 268 | 58 | 5 | 33640491 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.76e-05 | 861 | 58 | 8 | 36931259 | |
| Pubmed | 9.04e-05 | 638 | 58 | 7 | 33239621 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.20e-05 | 440 | 58 | 6 | 34244565 | |
| Pubmed | 9.31e-05 | 641 | 58 | 7 | 36057605 | ||
| Pubmed | 9.31e-05 | 441 | 58 | 6 | 31239290 | ||
| Pubmed | A family of unconventional deubiquitinases with modular chain specificity determinants. | 9.77e-05 | 9 | 58 | 2 | 29476094 | |
| Pubmed | 1.06e-04 | 655 | 58 | 7 | 35819319 | ||
| Pubmed | 1.21e-04 | 57 | 58 | 3 | 38223760 | ||
| Interaction | SNRNP40 interactions | CASP8AP2 CWF19L2 MIS18BP1 SNW1 TCERG1 PNN UBR5 PRPF3 NOP53 NUMA1 SCAF11 RPA1 EPB41L2 PHF21A | 2.42e-09 | 637 | 58 | 14 | int:SNRNP40 |
| Interaction | NUP62 interactions | 8.03e-08 | 273 | 58 | 9 | int:NUP62 | |
| Interaction | BUB1B interactions | 8.43e-08 | 195 | 58 | 8 | int:BUB1B | |
| Interaction | SMC5 interactions | SART3 CWF19L2 SNW1 MAP7D3 TCERG1 PNN PRPF3 CCDC174 NOP53 NUMA1 MCM3 SCAF11 MPHOSPH8 RPA1 MEF2D | 9.80e-08 | 1000 | 58 | 15 | int:SMC5 |
| Interaction | U2AF2 interactions | EZR CASP8AP2 LUC7L SNW1 SMG7 TCERG1 PNN UBR5 PRPF3 NUMA1 SCAF11 RPA1 | 2.67e-07 | 651 | 58 | 12 | int:U2AF2 |
| Interaction | PML interactions | SART3 EZR CASP8AP2 EME1 CWF19L2 SNW1 TCERG1 UBR5 PRPF3 NUMA1 HNF4A MEF2D EPB41L2 PHF21A | 2.85e-07 | 933 | 58 | 14 | int:PML |
| Interaction | SLX4 interactions | EME1 CWF19L2 MIS18BP1 SNW1 NUP155 UBR5 PRPF3 NOP53 NUMA1 HNF4A RPA1 | 5.94e-07 | 572 | 58 | 11 | int:SLX4 |
| Interaction | AR interactions | SART3 ZBTB32 SNW1 PNN UBR5 PRPF3 C16orf87 NUMA1 MCM3 CEP131 HNF4A RPA1 MEF2D PHF21A | 5.97e-07 | 992 | 58 | 14 | int:AR |
| Interaction | RAD18 interactions | 6.42e-07 | 457 | 58 | 10 | int:RAD18 | |
| Interaction | SCOC interactions | 7.36e-07 | 59 | 58 | 5 | int:SCOC | |
| Interaction | MOB3C interactions | 9.05e-07 | 364 | 58 | 9 | int:MOB3C | |
| Interaction | DDX23 interactions | 1.00e-06 | 480 | 58 | 10 | int:DDX23 | |
| Interaction | PPIA interactions | PNN CCDC174 ITSN1 OTUD1 MCM3 MPHOSPH8 CEP131 HEATR5A ANKRD36 RPA1 MAP2K6 MEF2D TFE3 | 1.08e-06 | 888 | 58 | 13 | int:PPIA |
| Interaction | ARID5B interactions | 1.40e-06 | 67 | 58 | 5 | int:ARID5B | |
| Interaction | SNRPF interactions | 1.44e-06 | 385 | 58 | 9 | int:SNRPF | |
| Interaction | H2AC4 interactions | SART3 LUC7L UBR5 PRPF3 C16orf87 NUMA1 SCAF11 EXOC7 RPA1 EPB41L2 | 1.61e-06 | 506 | 58 | 10 | int:H2AC4 |
| Interaction | DHX8 interactions | 1.81e-06 | 292 | 58 | 8 | int:DHX8 | |
| Interaction | MIB1 interactions | 1.95e-06 | 295 | 58 | 8 | int:MIB1 | |
| Interaction | NKAP interactions | 2.16e-06 | 132 | 58 | 6 | int:NKAP | |
| Interaction | ACIN1 interactions | 2.26e-06 | 301 | 58 | 8 | int:ACIN1 | |
| Interaction | BUB1 interactions | 2.68e-06 | 137 | 58 | 6 | int:BUB1 | |
| Interaction | NAA40 interactions | SART3 SNW1 FAM193A SMG7 MAP7D3 TCERG1 PNN PRPF3 NUMA1 KLC4 RPA1 EPB41L2 PHF21A | 3.15e-06 | 978 | 58 | 13 | int:NAA40 |
| Interaction | RNPS1 interactions | 3.23e-06 | 425 | 58 | 9 | int:RNPS1 | |
| Interaction | NUP107 interactions | 3.24e-06 | 221 | 58 | 7 | int:NUP107 | |
| Interaction | RNF43 interactions | 3.36e-06 | 427 | 58 | 9 | int:RNF43 | |
| Interaction | HECTD1 interactions | SNW1 NUP155 MAP7D3 TCERG1 PNN CENPE PRPF3 NOP53 NUMA1 SCAF11 NKAP EXOC7 RPA1 | 3.37e-06 | 984 | 58 | 13 | int:HECTD1 |
| Interaction | AURKA interactions | SART3 EZR SNW1 TCERG1 CENPE UBR5 NOP53 OTUD1 NUMA1 CEP131 RPA1 | 3.99e-06 | 696 | 58 | 11 | int:AURKA |
| Interaction | PRP4K interactions | 4.37e-06 | 329 | 58 | 8 | int:PRP4K | |
| Interaction | PRPF40A interactions | 4.78e-06 | 446 | 58 | 9 | int:PRPF40A | |
| Interaction | BCR interactions | 6.22e-06 | 244 | 58 | 7 | int:BCR | |
| Interaction | GSK3A interactions | 6.59e-06 | 464 | 58 | 9 | int:GSK3A | |
| Interaction | RBPJ interactions | 8.09e-06 | 254 | 58 | 7 | int:RBPJ | |
| Interaction | YWHAG interactions | LUC7L MAP7D3 TCERG1 PNN MCM3 SCAF11 CEP131 NKAP KLC4 RPA1 MEF2D EPB41L2 TFE3 CCSER1 | 8.78e-06 | 1248 | 58 | 14 | int:YWHAG |
| Interaction | SNRPA interactions | 8.94e-06 | 482 | 58 | 9 | int:SNRPA | |
| Interaction | KMT2D interactions | 8.98e-06 | 169 | 58 | 6 | int:KMT2D | |
| Interaction | EFTUD2 interactions | SART3 EZR LUC7L CWF19L2 SNW1 NUP155 TCERG1 PNN UBR5 PRPF3 NUMA1 MCM3 SCAF11 RPA1 EPB41L2 | 1.03e-05 | 1449 | 58 | 15 | int:EFTUD2 |
| Interaction | RABEP1 interactions | 1.46e-05 | 184 | 58 | 6 | int:RABEP1 | |
| Interaction | SNRPB interactions | 1.56e-05 | 517 | 58 | 9 | int:SNRPB | |
| Interaction | TNRC6B interactions | 1.59e-05 | 282 | 58 | 7 | int:TNRC6B | |
| Interaction | KPNA2 interactions | 1.61e-05 | 519 | 58 | 9 | int:KPNA2 | |
| Interaction | CPSF6 interactions | 1.79e-05 | 526 | 58 | 9 | int:CPSF6 | |
| Interaction | AQR interactions | 1.85e-05 | 192 | 58 | 6 | int:AQR | |
| Interaction | CHD8 interactions | 1.91e-05 | 193 | 58 | 6 | int:CHD8 | |
| Interaction | RBM33 interactions | 2.17e-05 | 117 | 58 | 5 | int:RBM33 | |
| Interaction | NUPR1 interactions | 2.24e-05 | 683 | 58 | 10 | int:NUPR1 | |
| Interaction | PNN interactions | 2.47e-05 | 302 | 58 | 7 | int:PNN | |
| Interaction | SRSF11 interactions | 2.54e-05 | 203 | 58 | 6 | int:SRSF11 | |
| Interaction | CDC5L interactions | LUC7L CWF19L2 SNW1 NUP155 PNN UBR5 PRPF3 OTUD1 MCM3 EXOC7 RPA1 | 2.75e-05 | 855 | 58 | 11 | int:CDC5L |
| Interaction | NUF2 interactions | 2.76e-05 | 123 | 58 | 5 | int:NUF2 | |
| Interaction | DVL2 interactions | 2.81e-05 | 557 | 58 | 9 | int:DVL2 | |
| Interaction | MEN1 interactions | SART3 LUC7L SNW1 TCERG1 PNN UBR5 PRPF3 NOP53 NUMA1 SCAF11 RPA1 MEF2D | 2.97e-05 | 1029 | 58 | 12 | int:MEN1 |
| Interaction | PPIG interactions | 3.22e-05 | 127 | 58 | 5 | int:PPIG | |
| Interaction | SNRPC interactions | 3.57e-05 | 440 | 58 | 8 | int:SNRPC | |
| Interaction | KRT8 interactions | 3.63e-05 | 441 | 58 | 8 | int:KRT8 | |
| Interaction | WIZ interactions | 3.98e-05 | 220 | 58 | 6 | int:WIZ | |
| Interaction | SUMO2 interactions | 4.46e-05 | 591 | 58 | 9 | int:SUMO2 | |
| Interaction | YWHAE interactions | SESTD1 MAP7D3 CENPE OTUD1 ROCK1 SCAF11 CEP131 KLC4 LCP2 RPA1 EPB41L2 TFE3 CCSER1 | 4.56e-05 | 1256 | 58 | 13 | int:YWHAE |
| Interaction | CIT interactions | EZR LUC7L SNW1 NUP155 TCERG1 PNN PRPF3 NOP53 NUMA1 MCM3 SCAF11 MPHOSPH8 HEATR5A CCSER1 | 4.70e-05 | 1450 | 58 | 14 | int:CIT |
| Interaction | NINL interactions | 4.74e-05 | 458 | 58 | 8 | int:NINL | |
| Interaction | CRYBG3 interactions | 4.91e-05 | 70 | 58 | 4 | int:CRYBG3 | |
| Interaction | OBI1 interactions | 4.96e-05 | 139 | 58 | 5 | int:OBI1 | |
| Interaction | NUP88 interactions | 5.13e-05 | 140 | 58 | 5 | int:NUP88 | |
| Interaction | APEX1 interactions | SART3 CWF19L2 FAM193A NOP53 ITSN1 NUMA1 SCAF11 CEP131 RHOT2 KLC4 EXOC7 RPA1 EPB41L2 | 5.15e-05 | 1271 | 58 | 13 | int:APEX1 |
| Interaction | ANAPC2 interactions | 5.62e-05 | 234 | 58 | 6 | int:ANAPC2 | |
| Interaction | EXOC1 interactions | 5.68e-05 | 143 | 58 | 5 | int:EXOC1 | |
| Interaction | CWF19L1 interactions | 6.12e-05 | 74 | 58 | 4 | int:CWF19L1 | |
| Interaction | FCHO1 interactions | 6.45e-05 | 75 | 58 | 4 | int:FCHO1 | |
| Interaction | LUC7L interactions | 6.77e-05 | 242 | 58 | 6 | int:LUC7L | |
| Interaction | ZNF830 interactions | 6.79e-05 | 76 | 58 | 4 | int:ZNF830 | |
| Interaction | NUP43 interactions | 6.87e-05 | 625 | 58 | 9 | int:NUP43 | |
| Interaction | ANAPC1 interactions | 7.59e-05 | 152 | 58 | 5 | int:ANAPC1 | |
| Interaction | UBE2O interactions | 7.67e-05 | 790 | 58 | 10 | int:UBE2O | |
| Interaction | SPTAN1 interactions | 8.28e-05 | 496 | 58 | 8 | int:SPTAN1 | |
| Interaction | EIF4A3 interactions | 8.63e-05 | 499 | 58 | 8 | int:EIF4A3 | |
| Interaction | SNRPB2 interactions | 9.03e-05 | 255 | 58 | 6 | int:SNRPB2 | |
| Interaction | MKI67 interactions | 9.05e-05 | 648 | 58 | 9 | int:MKI67 | |
| Interaction | VARS1 interactions | 1.00e-04 | 260 | 58 | 6 | int:VARS1 | |
| Interaction | RNF40 interactions | 1.03e-04 | 261 | 58 | 6 | int:RNF40 | |
| Interaction | SNRPD3 interactions | 1.05e-04 | 380 | 58 | 7 | int:SNRPD3 | |
| Interaction | MAPRE1 interactions | 1.06e-04 | 514 | 58 | 8 | int:MAPRE1 | |
| Interaction | TUBG1 interactions | 1.09e-04 | 382 | 58 | 7 | int:TUBG1 | |
| Interaction | TLN1 interactions | 1.09e-04 | 264 | 58 | 6 | int:TLN1 | |
| Interaction | MYCN interactions | SART3 LUC7L SNW1 NUP155 PNN PRPF3 NOP53 P3H1 NUMA1 MCM3 SCAF11 NKAP KLC4 | 1.13e-04 | 1373 | 58 | 13 | int:MYCN |
| Interaction | DDX41 interactions | 1.15e-04 | 166 | 58 | 5 | int:DDX41 | |
| Interaction | KIF5C interactions | 1.20e-04 | 88 | 58 | 4 | int:KIF5C | |
| Interaction | NAA10 interactions | 1.22e-04 | 168 | 58 | 5 | int:NAA10 | |
| Interaction | BCAS2 interactions | 1.23e-04 | 270 | 58 | 6 | int:BCAS2 | |
| Interaction | YEATS2 interactions | 1.25e-04 | 169 | 58 | 5 | int:YEATS2 | |
| Interaction | ZC3H14 interactions | 1.25e-04 | 169 | 58 | 5 | int:ZC3H14 | |
| Interaction | WAS interactions | 1.26e-04 | 89 | 58 | 4 | int:WAS | |
| Interaction | SRSF10 interactions | 1.26e-04 | 271 | 58 | 6 | int:SRSF10 | |
| Interaction | CFAP20 interactions | 1.37e-04 | 91 | 58 | 4 | int:CFAP20 | |
| Interaction | SSRP1 interactions | 1.38e-04 | 685 | 58 | 9 | int:SSRP1 | |
| Interaction | ARID1A interactions | 1.39e-04 | 276 | 58 | 6 | int:ARID1A | |
| Interaction | NUP58 interactions | 1.43e-04 | 92 | 58 | 4 | int:NUP58 | |
| Interaction | TNIP1 interactions | EZR LUC7L NUP155 MAP7D3 TCERG1 PNN PRPF3 NOP53 NUMA1 MCM3 RPA1 PHF21A | 1.49e-04 | 1217 | 58 | 12 | int:TNIP1 |
| Interaction | TNRC6A interactions | 1.51e-04 | 280 | 58 | 6 | int:TNRC6A | |
| Interaction | DVL3 interactions | 1.51e-04 | 280 | 58 | 6 | int:DVL3 | |
| Interaction | DIAPH1 interactions | 1.51e-04 | 176 | 58 | 5 | int:DIAPH1 | |
| Interaction | PATL1 interactions | 1.55e-04 | 177 | 58 | 5 | int:PATL1 | |
| Cytoband | 4q22.1 | 5.00e-04 | 26 | 58 | 2 | 4q22.1 | |
| Cytoband | 6q25.3 | 8.08e-04 | 33 | 58 | 2 | 6q25.3 | |
| Cytoband | Xp11.22 | 2.15e-03 | 54 | 58 | 2 | Xp11.22 | |
| Cytoband | 19q13.1 | 2.23e-03 | 55 | 58 | 2 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q22 | 4.00e-03 | 74 | 58 | 2 | chr4q22 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.33e-08 | 199 | 58 | 8 | M5893 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | SART3 EME1 MIS18BP1 CENPE SNX25 MCM3 ROCK1 CEP131 RHOT2 RPA1 USP1 | 4.86e-08 | 578 | 58 | 11 | M2368 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MIS18BP1 MAP7D3 PNN UBR5 SYTL3 NOP53 NUMA1 GPRIN3 ROCK1 SCAF11 MPHOSPH8 ITGA1 LCP2 RPA1 USP1 MEF2D | 9.21e-08 | 1492 | 58 | 16 | M40023 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | CASP8AP2 LUC7L MIS18BP1 NUP155 PNN CENPE MCM3 ROCK1 RPA1 USP1 | 3.50e-07 | 555 | 58 | 10 | M2343 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 6.80e-07 | 597 | 58 | 10 | MM1309 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 3.62e-06 | 187 | 58 | 6 | M2984 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.29e-06 | 426 | 58 | 8 | M9516 | |
| Coexpression | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP | 6.77e-06 | 55 | 58 | 4 | M2180 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 CWF19L2 MIS18BP1 PNN CENPE SCAF11 MPHOSPH8 NKAP USP1 | 1.30e-05 | 656 | 58 | 9 | M18979 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.90e-05 | 402 | 58 | 7 | MM454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | SART3 CASP8AP2 SESTD1 NUP155 MAP7D3 CENPE MCM3 CEP131 ANKRD36 RPA1 USP1 EPB41L2 | 3.59e-05 | 1363 | 58 | 12 | M45782 |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 3.86e-05 | 171 | 58 | 5 | M5655 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 4.58e-05 | 432 | 58 | 7 | MM419 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 4.93e-05 | 180 | 58 | 5 | M2961 | |
| Coexpression | GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP | 4.93e-05 | 180 | 58 | 5 | M2941 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN | 5.06e-05 | 181 | 58 | 5 | M7006 | |
| Coexpression | GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN | 5.61e-05 | 185 | 58 | 5 | M2939 | |
| Coexpression | VEGF_A_UP.V1_DN | 6.86e-05 | 193 | 58 | 5 | M2675 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_UP | 7.20e-05 | 195 | 58 | 5 | M9984 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | SART3 SESTD1 CWF19L2 MIS18BP1 C16orf87 NUMA1 MCM3 MPHOSPH8 NKAP LCP2 MAP2K6 | 7.41e-05 | 1239 | 58 | 11 | M1743 |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 7.93e-05 | 199 | 58 | 5 | M8619 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 8.12e-05 | 200 | 58 | 5 | M3580 | |
| Coexpression | HALLMARK_E2F_TARGETS | 8.12e-05 | 200 | 58 | 5 | M5925 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN | 8.12e-05 | 200 | 58 | 5 | M9037 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | SART3 SESTD1 CWF19L2 MIS18BP1 C16orf87 NUMA1 MCM3 MPHOSPH8 NKAP LCP2 MAP2K6 | 9.69e-05 | 1277 | 58 | 11 | MM1032 |
| Coexpression | PATIL_LIVER_CANCER | 9.78e-05 | 660 | 58 | 8 | M1195 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CASP8AP2 LUC7L EME1 CWF19L2 SNW1 NUP155 UBR5 C16orf87 MCM3 RPA1 USP1 | 1.06e-04 | 1290 | 58 | 11 | M80 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | 1.38e-04 | 694 | 58 | 8 | M45767 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 1.55e-04 | 904 | 58 | 9 | M2325 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 1.80e-04 | 922 | 58 | 9 | MM1068 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 2.05e-04 | 550 | 58 | 7 | M16189 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CASP8AP2 MIS18BP1 NUP155 CENPE MCM3 CEP131 ANKRD36 USP1 EPB41L2 | 2.06e-04 | 939 | 58 | 9 | M45768 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 2.58e-04 | 571 | 58 | 7 | MM1100 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 2.59e-04 | 761 | 58 | 8 | M11961 | |
| Coexpression | FISCHER_DREAM_TARGETS | 2.60e-04 | 969 | 58 | 9 | M149 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 3.89e-04 | 434 | 58 | 6 | M15150 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 3.89e-04 | 1024 | 58 | 9 | M1742 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_UP | 3.99e-04 | 156 | 58 | 4 | M17225 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 4.49e-04 | 161 | 58 | 4 | M6848 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 4.60e-04 | 448 | 58 | 6 | MM1044 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 4.84e-04 | 634 | 58 | 7 | M40866 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_DN | 4.93e-04 | 165 | 58 | 4 | M2960 | |
| Coexpression | MUELLER_PLURINET | 5.22e-04 | 299 | 58 | 5 | M123 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 5.28e-04 | 168 | 58 | 4 | M18811 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 5.43e-04 | 1072 | 58 | 9 | MM1031 | |
| Coexpression | BENPORATH_CYCLING_GENES | 5.51e-04 | 648 | 58 | 7 | M8156 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 5.52e-04 | 170 | 58 | 4 | M5657 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 5.66e-04 | 856 | 58 | 8 | M4500 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 7.27e-04 | 183 | 58 | 4 | M2993 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 8.36e-04 | 190 | 58 | 4 | M761 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 9.03e-04 | 194 | 58 | 4 | M7467 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 9.09e-04 | 1399 | 58 | 10 | M535 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 9.24e-04 | 86 | 58 | 3 | M39247 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP | 9.38e-04 | 196 | 58 | 4 | M4530 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP | 9.38e-04 | 196 | 58 | 4 | M3668 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 9.43e-04 | 341 | 58 | 5 | M2879 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 9.56e-04 | 197 | 58 | 4 | M8166 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 9.56e-04 | 197 | 58 | 4 | M7546 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 9.73e-04 | 714 | 58 | 7 | M1744 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 9.74e-04 | 198 | 58 | 4 | M9346 | |
| Coexpression | GSE29618_PDC_VS_MDC_UP | 9.74e-04 | 198 | 58 | 4 | M4951 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 9.74e-04 | 198 | 58 | 4 | M6128 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_UP | 9.74e-04 | 198 | 58 | 4 | M3168 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_DN | 9.84e-04 | 21 | 58 | 2 | M12459 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_DN | 9.93e-04 | 199 | 58 | 4 | M5146 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | 9.93e-04 | 199 | 58 | 4 | M3262 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 9.93e-04 | 199 | 58 | 4 | M7651 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 9.93e-04 | 199 | 58 | 4 | M7985 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN | 9.93e-04 | 199 | 58 | 4 | M4036 | |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN | 9.93e-04 | 199 | 58 | 4 | M3420 | |
| Coexpression | GSE17721_CTRL_VS_CPG_24H_BMDC_DN | 9.93e-04 | 199 | 58 | 4 | M3772 | |
| Coexpression | GSE3982_MAC_VS_TH1_DN | 9.93e-04 | 199 | 58 | 4 | M5511 | |
| Coexpression | GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP | 9.93e-04 | 199 | 58 | 4 | M6934 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.01e-03 | 200 | 58 | 4 | M5041 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP | 1.01e-03 | 200 | 58 | 4 | M6403 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 1.01e-03 | 200 | 58 | 4 | M107 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN | 1.01e-03 | 200 | 58 | 4 | M6358 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.01e-03 | 200 | 58 | 4 | M6614 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.01e-03 | 200 | 58 | 4 | M5901 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 1.01e-03 | 200 | 58 | 4 | M7839 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.01e-03 | 200 | 58 | 4 | M8608 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 1.01e-03 | 200 | 58 | 4 | M8648 | |
| Coexpression | GSE3982_MAC_VS_TH2_DN | 1.01e-03 | 200 | 58 | 4 | M5514 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 1.01e-03 | 200 | 58 | 4 | M6745 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN | 1.01e-03 | 200 | 58 | 4 | M9275 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 1.01e-03 | 200 | 58 | 4 | M7505 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.01e-03 | 200 | 58 | 4 | M8842 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.01e-03 | 200 | 58 | 4 | M8877 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 1.01e-03 | 200 | 58 | 4 | M3188 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP | 1.01e-03 | 200 | 58 | 4 | M6234 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP | 1.01e-03 | 200 | 58 | 4 | M6038 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 1.01e-03 | 200 | 58 | 4 | M8765 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN | 1.01e-03 | 200 | 58 | 4 | M5600 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | CASP8AP2 NUP155 MAP7D3 CENPE MCM3 CEP131 BSCL2 ANKRD36 RPA1 EPB41L2 | 1.04e-03 | 1423 | 58 | 10 | M45722 |
| Coexpression | EGUCHI_CELL_CYCLE_RB1_TARGETS | 1.08e-03 | 22 | 58 | 2 | M4455 | |
| Coexpression | YUAN_ZNF143_PARTNERS | 1.08e-03 | 22 | 58 | 2 | M2355 | |
| Coexpression | DE_YY1_TARGETS_DN | 1.16e-03 | 93 | 58 | 3 | M3278 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SART3 CASP8AP2 EME1 CWF19L2 SNW1 NUP155 SMG7 TCERG1 PNN CENPE UBR5 C16orf87 ROCK1 SCAF11 MPHOSPH8 HEATR5A USP1 | 3.59e-14 | 532 | 58 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.43e-09 | 192 | 58 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | EZR CASP8AP2 EME1 CWF19L2 MAP7D3 TCERG1 PNN CENPE UBR5 ROCK1 MPHOSPH8 | 8.90e-08 | 498 | 58 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SART3 CASP8AP2 EME1 CWF19L2 FAM193A TCERG1 PNN CENPE UBR5 NUMA1 MPHOSPH8 NKAP KLC4 | 2.84e-07 | 831 | 58 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SART3 EZR CASP8AP2 EME1 CWF19L2 FAM193A SMG7 MAP7D3 TCERG1 PNN CENPE UBR5 ROCK1 MPHOSPH8 | 3.07e-07 | 989 | 58 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | EME1 CWF19L2 MIS18BP1 SNW1 TCERG1 PNN CENPE ROCK1 SCAF11 HEATR5A | 5.07e-07 | 469 | 58 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 7.29e-07 | 186 | 58 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 EME1 CWF19L2 MIS18BP1 PUS3 FAM193A TCERG1 PNN CENPE ROCK1 SCAF11 MPHOSPH8 RPA1 USP1 CCSER1 | 9.43e-07 | 1257 | 58 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | EME1 MIS18BP1 FAM193A PNN CENPE CCDC174 NUMA1 ROCK1 SCAF11 MPHOSPH8 NKAP USP1 | 1.05e-06 | 780 | 58 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | EZR CASP8AP2 EME1 CWF19L2 MIS18BP1 PUS3 FAM193A TCERG1 PNN CENPE ROCK1 SCAF11 MPHOSPH8 RPA1 USP1 CCSER1 | 1.15e-06 | 1459 | 58 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.96e-06 | 311 | 58 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.18e-06 | 232 | 58 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 6.95e-06 | 492 | 58 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 7.07e-06 | 493 | 58 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 EME1 CWF19L2 PNN CENPE UBR5 MPHOSPH8 BSCL2 USP1 PHF21A | 9.85e-06 | 654 | 58 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.38e-05 | 192 | 58 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.40e-05 | 291 | 58 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SLC7A9 RGL1 CWF19L2 MIS18BP1 PUS3 CENPE MCM3 ROCK1 SCAF11 EPB41L2 | 5.75e-05 | 804 | 58 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | EZR CASP8AP2 EME1 CWF19L2 PNN CENPE UBR5 ROCK1 MPHOSPH8 USP1 CCSER1 | 6.10e-05 | 983 | 58 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.14e-05 | 376 | 58 | 7 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.40e-05 | 259 | 58 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.49e-05 | 271 | 58 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.08e-04 | 402 | 58 | 7 | GSM605898_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.22e-04 | 410 | 58 | 7 | GSM538387_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.59e-04 | 298 | 58 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | EZR CASP8AP2 EME1 MIS18BP1 NUP155 TCERG1 PNN CENPE MCM3 MPHOSPH8 RPA1 USP1 | 2.36e-04 | 1347 | 58 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | CASP8AP2 EME1 MIS18BP1 NUP155 TCERG1 PNN CENPE MCM3 MPHOSPH8 RPA1 USP1 | 2.71e-04 | 1164 | 58 | 11 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | EME1 MIS18BP1 PNN CENPE CCDC174 ROCK1 SCAF11 MPHOSPH8 USP1 CCSER1 | 3.03e-04 | 985 | 58 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.41e-04 | 815 | 58 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 3.68e-04 | 124 | 58 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.72e-04 | 492 | 58 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 EME1 CWF19L2 MIS18BP1 PNN CENPE SNX25 ROCK1 SCAF11 CEP131 USP1 | 4.67e-04 | 1241 | 58 | 11 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.57e-04 | 246 | 58 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 6.55e-04 | 255 | 58 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 7.43e-04 | 398 | 58 | 6 | GSM399397_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 7.92e-04 | 403 | 58 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2 | 8.77e-04 | 411 | 58 | 6 | GSM791112_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | CASP8AP2 EME1 CWF19L2 MIS18BP1 TCERG1 PNN CENPE MCM3 MPHOSPH8 RHOT2 USP1 | 1.07e-03 | 1371 | 58 | 11 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.25e-03 | 978 | 58 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.28e-03 | 173 | 58 | 4 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.31e-03 | 298 | 58 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 1.33e-03 | 986 | 58 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 1.40e-03 | 994 | 58 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.49e-03 | 806 | 58 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.32e-07 | 199 | 58 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-07 | 199 | 58 | 6 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-07 | 199 | 58 | 6 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-06 | 178 | 58 | 5 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-06 | 180 | 58 | 5 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-06 | 180 | 58 | 5 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-06 | 183 | 58 | 5 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-06 | 185 | 58 | 5 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.51e-06 | 187 | 58 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.39e-06 | 194 | 58 | 5 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.39e-06 | 194 | 58 | 5 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.81e-06 | 197 | 58 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.95e-06 | 198 | 58 | 5 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-06 | 199 | 58 | 5 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-06 | 199 | 58 | 5 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.25e-06 | 200 | 58 | 5 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 6.25e-06 | 200 | 58 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 6.25e-06 | 200 | 58 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.25e-06 | 200 | 58 | 5 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.16e-05 | 138 | 58 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.05e-05 | 147 | 58 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-05 | 163 | 58 | 4 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-05 | 164 | 58 | 4 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-05 | 164 | 58 | 4 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 167 | 58 | 4 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.96e-05 | 169 | 58 | 4 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 170 | 58 | 4 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 170 | 58 | 4 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-05 | 171 | 58 | 4 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-05 | 171 | 58 | 4 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 35dc897e06f905419d44093a92170d2cec35dd51 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 37825d0dda028cf677ff6ff16ea58bff75cb25a7 | |
| ToppCell | Club-club-15|World / Class top | 7.96e-05 | 175 | 58 | 4 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-05 | 176 | 58 | 4 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-05 | 176 | 58 | 4 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 178 | 58 | 4 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.51e-05 | 178 | 58 | 4 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 179 | 58 | 4 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 180 | 58 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.07e-05 | 181 | 58 | 4 | 9275531e896e118cee043ed94fd31a0070d9581c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 183 | 58 | 4 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 186 | 58 | 4 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.01e-04 | 186 | 58 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 1.05e-04 | 188 | 58 | 4 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 189 | 58 | 4 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | 390C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 190 | 58 | 4 | f63c9474f23bb72f0bb1fc531342f0da04ed8b3e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.09e-04 | 190 | 58 | 4 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 190 | 58 | 4 | c3c65d1f24e0ebdbb9adb617bed299a668f423f5 | |
| ToppCell | 390C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 190 | 58 | 4 | 53bf211f0e8a44f5adb89c43b210a1e35120b6a8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-04 | 191 | 58 | 4 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 191 | 58 | 4 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.14e-04 | 192 | 58 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.14e-04 | 192 | 58 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Treg|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 192 | 58 | 4 | b7e08cadb50f66c2efdde45e0fa8bab29367269b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 192 | 58 | 4 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-04 | 193 | 58 | 4 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 58 | 4 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-04 | 193 | 58 | 4 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.19e-04 | 194 | 58 | 4 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.19e-04 | 194 | 58 | 4 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | COVID-19_Severe-B_intermediate|COVID-19_Severe / disease group, cell group and cell class | 1.19e-04 | 194 | 58 | 4 | 3418308da7f1278ae2bf3fb61fc361b222e30043 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 194 | 58 | 4 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-04 | 194 | 58 | 4 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 195 | 58 | 4 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | (0)_NK/T_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.23e-04 | 196 | 58 | 4 | baee29014dc56c71a6ef790bb7ecd5b5271cfcb0 | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.23e-04 | 196 | 58 | 4 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-04 | 196 | 58 | 4 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 196 | 58 | 4 | fd756b247b2d8a291e8e71bec6f1e463d6557536 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 196 | 58 | 4 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-04 | 196 | 58 | 4 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.23e-04 | 196 | 58 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | PSB-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 196 | 58 | 4 | 7b5c2a4cdea9a944f83bfc2c493d3076c3daaeaa | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 196 | 58 | 4 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 197 | 58 | 4 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 197 | 58 | 4 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 197 | 58 | 4 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 197 | 58 | 4 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 197 | 58 | 4 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 197 | 58 | 4 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 197 | 58 | 4 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | NS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-04 | 198 | 58 | 4 | e2acb074142aa62c763139bbcf36f6f85038d04b | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-04 | 198 | 58 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.28e-04 | 198 | 58 | 4 | 1fa0ea06453d6b979039f63454e7f9c69323a350 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 198 | 58 | 4 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.28e-04 | 198 | 58 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-04 | 198 | 58 | 4 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-04 | 198 | 58 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 198 | 58 | 4 | becd5ae642f8de541ac790fdca45cf6394f05cd4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-04 | 199 | 58 | 4 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| Computational | Neighborhood of MSH2 | 1.16e-04 | 28 | 37 | 3 | GNF2_MSH2 | |
| Computational | Neighborhood of MLH1 | 3.93e-04 | 42 | 37 | 3 | GNF2_MLH1 | |
| Computational | DNA replication. | 4.21e-04 | 43 | 37 | 3 | MODULE_158 | |
| Computational | Genes in the cancer module 125. | 4.51e-04 | 44 | 37 | 3 | MODULE_125 | |
| Computational | Neighborhood of HAT1 | 6.58e-04 | 50 | 37 | 3 | GNF2_HAT1 | |
| Computational | Neighborhood of DEK | 1.02e-03 | 58 | 37 | 3 | GNF2_DEK | |
| Computational | Neighborhood of RPA1 | 1.18e-03 | 61 | 37 | 3 | MORF_RPA1 | |
| Computational | Neighborhood of MSH2 | 1.18e-03 | 61 | 37 | 3 | MORF_MSH2 | |
| Computational | TFs and nuclear. | 1.22e-03 | 237 | 37 | 5 | MODULE_252 | |
| Disease | NG-monomethyl-arginine measurement | 1.92e-04 | 11 | 56 | 2 | EFO_0010510 | |
| Disease | bitter non-alcoholic beverage consumption measurement | 1.69e-03 | 32 | 56 | 2 | EFO_0010093 | |
| Disease | ornithine measurement | 3.18e-03 | 44 | 56 | 2 | EFO_0009776 | |
| Disease | migraine disorder | 4.72e-03 | 357 | 56 | 4 | MONDO_0005277 | |
| Disease | peripheral arterial disease | 4.75e-03 | 54 | 56 | 2 | EFO_0004265 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 4.75e-03 | 54 | 56 | 2 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | phospholipids in medium HDL measurement | 4.93e-03 | 55 | 56 | 2 | EFO_0022295 | |
| Disease | free cholesterol in medium HDL measurement | 5.46e-03 | 58 | 56 | 2 | EFO_0022267 | |
| Disease | total lipids in medium HDL measurement | 5.46e-03 | 58 | 56 | 2 | EFO_0022310 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLEKQRESRQRLETE | 1586 | A6QL64 | |
| EDQTRRSVKQSTRKL | 166 | Q9C0I3 | |
| KKLERQSERSQNINR | 341 | Q9UKL3 | |
| SITEQKREERKVNSN | 1091 | P78312 | |
| SSVKENQKRTQRRLQ | 391 | Q9NZL6 | |
| KQKSERETAVRISQE | 406 | Q32P28 | |
| STVESEKQKLRAQVR | 96 | Q9NSK0 | |
| QTQVQRKRDEELAKS | 451 | Q5VV17 | |
| LATTEKKTEQQRRRE | 331 | Q9NZM5 | |
| TEEKRQRERQQESKI | 186 | Q8NDB6 | |
| ERTNERIIKSQKQET | 601 | Q6P0N0 | |
| TVAEKQEKRNQDRLR | 231 | Q9NQ29 | |
| QSSLRRQKREKETSE | 56 | O43491 | |
| KKEAVQNERDRISTR | 126 | P41235 | |
| FKQESTVATERQKRR | 156 | Q9H307 | |
| KSIEERKEQTRNARA | 16 | Q2TBE0 | |
| EEIQSKRQERKRRTT | 381 | Q96BD5 | |
| QERKVQRNITVRKSE | 741 | P56199 | |
| RDRIRQAQKTIVKET | 681 | Q9UPT5 | |
| LQRSRQVQNKTEKER | 881 | O75694 | |
| SQEDQEQKRKRRKTR | 681 | P25205 | |
| KITVRSNNREVAKRN | 331 | P27694 | |
| SRNDVREKQKTLVEQ | 41 | Q86XA9 | |
| ERVRREKINSTVNKD | 66 | Q6PH81 | |
| LRKRREDEKSIQSQE | 6 | P82251 | |
| QRQEIESTNKSRELR | 506 | Q15811 | |
| AKERRKQDVVNRVAT | 31 | Q8IWC1 | |
| REQTTDQRTKRENIK | 271 | Q6PII3 | |
| QSRLEKERAQRANKE | 616 | Q9NQR7 | |
| QKESTLRRQERKNAA | 221 | Q96AY2 | |
| QQLETEKKRRETVER | 321 | P15311 | |
| KRITEAEKNERVQRQ | 516 | P15311 | |
| RKNQESTLEENRQTK | 586 | Q6ZVF9 | |
| QVNIRKRDNSRKEVQ | 271 | Q96G97 | |
| VQKTETRLARVNEQR | 566 | Q15020 | |
| ETSRENKRSQPRVKD | 886 | Q99590 | |
| QQRDLTARRVKETEK | 596 | Q9UPN4 | |
| KTQELQEKTREVQER | 871 | Q02224 | |
| QTRREAQKELQEKVR | 451 | O43395 | |
| ITDERNRQVTFTKRK | 11 | Q14814 | |
| NKQSLKERRNTRDET | 486 | Q99549 | |
| NQEERRKRENKILAS | 386 | Q8N5F7 | |
| RSEQQKATEKERVAQ | 681 | Q14980 | |
| VKRIRATVNSQEQKR | 81 | P52564 | |
| QAVQNTEEERTRKLK | 26 | Q4VX76 | |
| TDRNQTEKLLKRVRE | 6 | Q9BZE2 | |
| REKRLDQEKGQTQRS | 401 | Q8IXI1 | |
| TTIRSKEQSQETKQR | 756 | Q9H3E2 | |
| TFKENIKTREVNRDQ | 546 | Q92540 | |
| RQRSKRTQLEEIQQK | 266 | Q86VW0 | |
| REKETRNTLKNTLEN | 341 | A4D1E1 | |
| KEQQRSKDLESRQRS | 401 | P19532 | |
| EREREVQKARSEQTK | 871 | O14776 | |
| KRTTTEDENEKLRQQ | 461 | Q5TF21 | |
| KRSKLQRNENRDISE | 376 | Q13573 | |
| NEKRRNVENEVSTLK | 506 | Q13464 | |
| TQEAQQEQTRSKEKR | 181 | Q9Y2Y4 | |
| QSLEENQRQTRSKRK | 291 | O94782 | |
| LVDSSEKVQQENRKR | 2466 | O95071 | |
| EINKNEERRSIFTRK | 71 | Q13094 |